PARD6B, an isoform of PAR6, is also elevated in breast cancers in which PAR6 binding to aPKC and CDC42 activates the MEK (mitogen-activated protein kinase kinase)/ERK (extracellular signal-regulated kinase) pathway raising cell proliferation and acinar hyperplasia [50]. Here, CDC42 is linked to breast carcinoma.